Barclays’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-197,432
| Closed | -$3.72M | – | 4519 |
|
|
2019
Q3 | $3.72M | Buy |
197,432
+70,906
| +56% | +$1.34M | ﹤0.01% | 1274 |
|
|
2019
Q2 | $1.49M | Buy |
126,526
+109,961
| +664% | +$1.29M | ﹤0.01% | 2041 |
|
|
2019
Q1 | $226K | Sell |
16,565
-70,914
| -81% | -$967K | ﹤0.01% | 2975 |
|
|
2018
Q4 | $896K | Buy |
87,479
+14,251
| +19% | +$146K | ﹤0.01% | 1892 |
|
|
2018
Q3 | $1.22M | Buy |
73,228
+38,753
| +112% | +$645K | ﹤0.01% | 2139 |
|
|
2018
Q2 | $544K | Sell |
34,475
-1,477
| -4% | -$23.3K | ﹤0.01% | 2225 |
|
|
2018
Q1 | $457K | Buy |
35,952
+22,545
| +168% | +$287K | ﹤0.01% | 2350 |
|
|
2017
Q4 | $154K | Sell |
13,407
-135,249
| -91% | -$1.55M | ﹤0.01% | 2799 |
|
|
2017
Q3 | $1.82M | Buy |
148,656
+135,490
| +1,029% | +$1.66M | ﹤0.01% | 1281 |
|
|
2017
Q2 | $150K | Sell |
13,166
-6,477
| -33% | -$73.8K | ﹤0.01% | 2589 |
|
|
2017
Q1 | $409K | Buy |
19,643
+7,086
| +56% | +$148K | ﹤0.01% | 2077 |
|
|
2016
Q4 | $262K | Buy |
12,557
+9,755
| +348% | +$204K | ﹤0.01% | 2170 |
|
|
2016
Q3 | $92K | Buy |
2,802
+1,992
| +246% | +$65.4K | ﹤0.01% | 2467 |
|
|
2016
Q2 | $20K | Sell |
810
-73,181
| -99% | -$1.81M | ﹤0.01% | 2821 |
|
|
2016
Q1 | $1.78M | Buy |
73,991
+71,519
| +2,893% | +$1.72M | ﹤0.01% | 1134 |
|
|
2015
Q4 | $81K | Sell |
2,472
-9,355
| -79% | -$307K | ﹤0.01% | 2368 |
|
|
2015
Q3 | $379K | Buy |
11,827
+11,418
| +2,792% | +$366K | ﹤0.01% | 1841 |
|
|
2015
Q2 | $22K | Sell |
409
-540
| -57% | -$29K | ﹤0.01% | 2940 |
|
|
2015
Q1 | $26K | Buy |
949
+299
| +46% | +$8.19K | ﹤0.01% | 3016 |
|
|
2014
Q4 | $19K | Sell |
650
-900
| -58% | -$26.3K | ﹤0.01% | 3457 |
|
|
2014
Q3 | $18K | Buy |
1,550
+1,374
| +781% | +$16K | ﹤0.01% | 3477 |
|
|
2014
Q2 | $4K | Buy |
+176
| New | +$4K | ﹤0.01% | 3983 |
|